Kindred Biosciences, Inc. KIN

Kindred Biosciences, Inc. DPO Ratio 2011-2026 | KIN

Annual DPO Ratio Kindred Biosciences, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
11.4	781	4.03 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.03 K	11.4	1.61 K

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	Aptorum Group Limited APM	405	$ 0.79	-0.79 %	$ 4.31 M	China
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	Anika Therapeutics ANIK	54.4	$ 14.36	1.13 %	$ 210 M	USA
	AVEO Pharmaceuticals AVEO	235	-	-	$ 521 M	USA
	Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
	Aytu BioScience AYTU	186	$ 2.64	3.94 %	$ 16.6 M	USA
	BioCardia BCDA	68.1 K	$ 1.27	0.79 %	$ 26.9 M	USA
	AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain